Switch theme
Sign up to access all valuation multiples
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
1997
94
Last FY Revenue $19.1M
Last FY EBITDA $5.4M
$44.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, MeVis achieved revenue of $19.1M and an EBITDA of $5.4M.
MeVis expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MeVis valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $19.1M | XXX | XXX | XXX |
| Gross Profit | XXX | $18.5M | XXX | XXX | XXX |
| Gross Margin | XXX | 97% | XXX | XXX | XXX |
| EBITDA | XXX | $5.4M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 29% | XXX | XXX | XXX |
| EBIT | XXX | $4.5M | XXX | XXX | XXX |
| EBIT Margin | XXX | 24% | XXX | XXX | XXX |
| Net Profit | XXX | $5.1M | XXX | XXX | XXX |
| Net Margin | XXX | 27% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, MeVis's stock price is EUR 25 (or $28).
MeVis has current market cap of EUR 45.9M (or $51.5M), and EV of EUR 39.3M (or $44.2M).
See MeVis trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $44.2M | $51.5M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, MeVis has market cap of $51.5M and EV of $44.2M.
MeVis's trades at 2.3x EV/Revenue multiple, and 7.7x EV/EBITDA.
Equity research analysts estimate MeVis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
MeVis's P/E ratio is not available.
See valuation multiples for MeVis and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $51.5M | XXX | $51.5M | XXX | XXX | XXX |
| EV (current) | $44.2M | XXX | $44.2M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 7.7x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 8.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 9.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 7.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMeVis's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
MeVis's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
MeVis's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for MeVis and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 74% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MeVis acquired XXX companies to date.
Last acquisition by MeVis was XXXXXXXX, XXXXX XXXXX XXXXXX . MeVis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was MeVis founded? | MeVis was founded in 1997. |
| Where is MeVis headquartered? | MeVis is headquartered in Germany. |
| How many employees does MeVis have? | As of today, MeVis has 94 employees. |
| Is MeVis publicy listed? | Yes, MeVis is a public company listed on ETR. |
| What is the stock symbol of MeVis? | MeVis trades under M3V ticker. |
| When did MeVis go public? | MeVis went public in 2007. |
| Who are competitors of MeVis? | Similar companies to MeVis include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of MeVis? | MeVis's current market cap is $51.5M |
| Is MeVis profitable? | Yes, MeVis is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
